Notices. Notice of information collection under OMB review

3,017 words·~14 min read·/register/2006/04/25/06-3944

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4410-11-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 20, 2005, August 4, 2005 and September 2, 2005, Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letters to the Drug Enforcement Administration

(DEA)for registration as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Codeine

(9050)II Dihydrocodeine

(9120)II Methadone

(9250)II Alfentanil

(9737)II The company plans to manufacture in bulk, for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than June 26, 2006. Dated: April 18, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-6115 Filed 4-24-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on September 16, 2005, Hospira, Inc., 1776 North Centennial Drive, McPherson, Kansas 67460-1247, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as an importer of Remifentanial (9739), a basic class of controlled substance listed in Schedule II. The company plans to import the basic class of controlled substance for use in dosage unit manufacturing. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 25, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d),

(e)and (f). As noted in a previous notice published in the **Federal Register** on September 23, 1975, (40 FR 43745-46), all applicants for registration to import a basic class of any controlled substance listed in Schedule I or II are, and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d),

(e)and

(f)are satisfied. Dated: April 18, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-6114 Filed 4-24-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR § 1301.34(a), this is notice that on November 15, 2005, Johnson Matthey Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as an importer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Phenylacetone

(8501)II Raw Opium

(9600)II Concentrate of Poppy Straw

(9670)II The company plans to import the listed controlled substances as raw materials for use in the manufacture of bulk controlled substances for distribution to its customers. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 25, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d),

(e)and

(f)are satisfied. Dated: April 18, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-6113 Filed 4-24-06; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in Schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on November 2, 2005, Noramco Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal to the Drug Enforcement Administration

(DEA)to be registered as an importer of the basic classes of controlled substances listed in Schedule II: Drug Schedule Raw Opium

(9600)II Concentrate of Poppy Straw

(9670)II The company plans to import the listed controlled substances to manufacture other controlled substances. Any manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 25, 2006. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d),

(e)and

(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II: Drug Schedule Codeine-N-Oxide

(9053)I Morphine-N-Oxide

(9307)I Amphetamine

(1100)II Codeine

(9050)II Dihydrocodeine

(9120)II Oxycodone

(9143)II Hydromorphone

(9150)II Hydrocodone

(9193)II Morphine

(9300)II Thebaine

(9333)II Sufentanil

(9740)II Fentanyl

(9801)II The company plans to manufacture small quantities of the Schedule I controlled substances for internal testing; the Schedule II controlled substances will be manufactured in bulk for distribution to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than June 26, 2006. Dated: April 18, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-6117 Filed 4-24-06; 8:45 am] BILLING CODE 4410-09-P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (06-027)] Notice of Information Collection Under OMB Review AGENCY: National Aeronautics and Space Administration (NASA). ACTION: Notice of information collection under OMB review. SUMMARY: The National Aeronautics and Space Administration, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995 (Pub. L. 04-13, 44 U.S.C. 3506(c)(2)(A)). DATES: All comments should be submitted within 30 calendar days from the date of this publication. ADDRESSES: All comments should be addressed to Desk Officer for NASA, Office of Information and Regulatory Affairs, Room 10236, New Executive Office Building, Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Requests for additional information or copies of the information collection instrument(s) and instructions should be directed to Mr. Walter Kit, NASA Reports Officer, NASA Headquarters, 300 E Street, SW., JE0000, Washington, DC 20546,

(202)358-1350, *Walter.Kit-1@nasa.gov.* SUPPLEMENTARY INFORMATION: I. Abstract The National Aeronautics and Space Administration

(NASA)is requesting approval for a new collection that will be used to voluntary collect ideas from the general public about ways to fulfill NASA's technology development challenges. II. Method of Collection NASA will utilize electronic methods to collect this information, via an on-line Web based form. III. Data *Title:* NASA Centennial Challenges Idea Submission Web Forms. *OMB Number:* 2700-0119. *Type of Review:* Extension of currently approved collection. *Affected Public:* Individuals or households. *Estimated Number of Respondents:* 300. *Estimated Time per Response:* .25 hours. *Estimated Total Annual Burden Hours:* 75. *Estimated Total Annual Cost:* $0. IV. Request for Comments Comments are invited on:

(1)Whether the proposed collection of information is necessary for the proper performance of the functions of NASA, including whether the information collected has practical utility;

(2)the accuracy of NASA's estimate of the burden (including hours and cost) of the proposed collection of information;

(3)ways to enhance the quality, utility, and clarity of the information to be collected; and

(4)ways to minimize the burden of the collection of information on respondents, including automated collection techniques or the use of other forms of information technology. Dated: April 17, 2006. Patricia L. Dunnington, Chief Information Officer. [FR Doc. E6-6118 Filed 4-24-06; 8:45 am] BILLING CODE 7510-13-P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (06-026)] NASA Advisory Council; Meeting AGENCY: National Aeronautics and Space Administration (NASA). ACTION: Notice of meeting. SUMMARY: In accordance with the Federal Advisory Committee Act, Public Law 92-463, as amended, the National Aeronautics and Space Administration announces a meeting of the NASA Advisory Council. DATES: Thursday, May 18, 2006, 8 a.m.-5 p.m. ADDRESSES: vonKarman Auditorium, Jet Propulsion Laboratory, 4800 Oak Grove Drive, Pasadena, CA 91109. FOR FURTHER INFORMATION CONTACT: Mr. Christopher Blackerby, Designated Federal Official, National Aeronautics and Space Administration, Washington, DC, 20546, 202/358-4688. SUPPLEMENTARY INFORMATION: The meeting will be open to the public up to the seating capacity of the room. The agenda for the meeting includes updates from each of the Council committees, including discussion and deliberation of potential recommendations. The Council Committees address NASA interests in the following areas: Aeronautics, Audit and Finance, Space Exploration, Human Capital, and Science. It is imperative that the meeting be held on this date to accommodate the scheduling priorities of the key participants. Dated: April 18, 2006. P. Diane Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. E6-6112 Filed 4-24-06; 8:45 am] BILLING CODE 7510-13-P NATIONAL FOUNDATION ON THE ARTS AND HUMANITIES Submission for OMB Review; Comment Request AGENCY: National Endowment for the Humanities; NFAH. ACTION: Notice. SUMMARY: The National Endowment for the Humanities

(NEH)has submitted the following public information collection request

(ICR)to the Office of Management and Budget

(OMB)for review and approval as required by the provisions of the Paperwork Reduction Act of 1995 (Pub. L. 104-13, 44 U.S.C. Chapter 35). Copies of this ICR, with applicable supporting documentation, may be obtained by calling Susan G. Daisey, Director, Office of Grant Management, the National Endowment for the Humanities (202-606-8494) or may be requested by e-mail to *sdaisey@neh.gov.* Comments should be sent to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the National Endowment for the Humanities, Office of Management and Budget, Room 10235, Washington, DC 20503 (202-395-7316), within 30 days from the date of this publication in the **Federal Register** . SUPPLEMENTARY INFORMATION: The Office of Management and Budget

(OMB)is particularly interested in comments which:

(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

(3)Enhance the quality, utility, and clarity of the information to be collected; and

(4)Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, *e.g.* , permitting electronic submissions of responses. *Agency:* National Endowment for the Humanities. *Title of Proposal:* Generic Clearance Authority for the National Endowment for the Humanities. *OMB Number:* 3136-0134. *Frequency of Collection:* On occasion. *Affected Public:* Applicants to NEH grant programs, reviewers of NEH grant applications, and NEH grantees. *Total Respondents:* 8,762. *Average Time per Response:* varied according to type of information collection. *Estimated Total Burden Hours:* 74,979 hours. *Total Annualized capital/startup costs:* 0. *Total annual costs (operating/maintaining systems or purchasing services):* 0. *Description:* This submission requests approval from OMB for a three year extension of NEH's currently approved generic clearance authority for all NEH information collections other than one-time evaluations, questionnaires and surveys. Generic clearance authority would include approval of forms and instructions for application to NEH grant programs, reporting forms for NEH grantees, panelists and reviewers and for program evaluation purposes. FOR FURTHER INFORMATION CONTACT: Ms. Susan G. Daisey, Director, Office of Grant Management, National Endowment for the Humanities, 1100 Pennsylvania Avenue, NW., Room 311, Washington, DC 20506, or by e-mail to: *sdaisey@neh.gov* . Telephone: 202-606-8494. Brett Bobley, Chief Information Officer, National Endowment for the Humanities. [FR Doc. E6-6123 Filed 4-24-06; 8:45 am] BILLING CODE 7536-01-P NATIONAL TRANSPORTATION SAFETY BOARD Sunshine Act Meeting Time: 9:30 a.m., Tuesday, May 2, 2006. Place: NTSB Conference Center, 429 L'Enfant Plaza, SW., Washington, DC 20594. Status: The two items are open to the public. Matters to be Considered: 7777 *Aircraft Accident Brief* —Crash During Takeoff in Icing conditions, Canadair, Ltd., CL-600-2A12, N873G, Montrose, Colorado, November 28, 2004. 7778 *Aircraft Accident Report* —Crash During Approach to Landing, Air Tahoma, Inc., Flight 185, Convair 580, N586P, Covington, Kentucky, August 13, 2004. News Media Contact: Ted Lopatkiewicz, Telephone:

(202)314-6100. Individuals requesting specific accommodations should contact Chris Bisett at

(202)314-6305 by Friday, April 28, 2006. The public may view the meeting via a live or archived Web cast by accessing a link under “News & Events” on the NTSB home page at *http://www.ntsb.gov.* FOR FURTHER INFORMATION CONTACT: Vicky D'Onofrio,

(202)314-6410. Dated: April 21, 2006. Vicky D'Onofrio, Federal Register Liaison Officer. [FR Doc. 06-3944 Filed 4-21-06; 1:51 pm]

Connectionstraces to 8

Traces to 8 documents

CFR

U.S. Code

3 references not yet in our index